We analyzed antiretroviral drug susceptibility in HIV-infected adults failing first-and second-
line antiretroviral treatment (ART) in Rakai, Uganda. Samples obtained from participants at …

Background: Little is known about prevalence of drug resistance among HIV-infected
Ugandans, a setting with over 15 years of public sector access to antiretroviral therapy (ART) …

Objective To determine the frequency and patterns of acquired antiretroviral drug resistance
in a rural primary health care programme in South Africa. Design Cross-sectional study …

Background: The South African national antiretroviral therapy roll-out program is entering its
sixth year, with over 570,000 adults accessing treatment. HIV-1 drug resistance is a potential …

Objective We describe phenotypic drug resistance, response to therapy, and genotypic
mutations among HIV-infected patients in Uganda taking antiretroviral medications for≥ 90 …

Background We assessed the prevalence of acquired HIV drug resistance (HIVDR) and
associated factors among patients receiving first-line antiretroviral therapy (ART) in Rwanda …

Objective: To characterize HIV-1 phenotypic resistance patterns and genotypic mutations
among patients taking antiretroviral medications in Uganda. Methods: We reviewed charts …

Background: We assessed risk factors for viremia and drug resistance among long-term
recipients of antiretroviral therapy (ART) in South Africa. Methods: In 2008, we conducted a …

Background Studies of patients failing second-line antiretroviral therapy (ART) in resource-
limited settings (RLS) are few. Evidence suggests most patients who appear to be …

We sought to determine the pattern of resistance-associated mutations (RAMs) among HIV-1-
infected children failing first-line antiretroviral therapy (ART) and ascertain their response to …